These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35424854)

  • 21. Co-Amorphous Screening for the Solubility Enhancement of Poorly Water-Soluble Mirabegron and Investigation of Their Intermolecular Interactions and Dissolution Behaviors.
    An JH; Lim C; Kiyonga AN; Chung IH; Lee IK; Mo K; Park M; Youn W; Choi WR; Suh YG; Jung K
    Pharmaceutics; 2018 Sep; 10(3):. PubMed ID: 30189645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
    Jug M; Maestrelli F; Bragagni M; Mura P
    J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amorphous Drug Solubility and Maximum Free Drug Concentrations in Cyclodextrin Solutions: A Quantitative Study Using NMR Diffusometry.
    Ueda K; Higashi K; Moribe K
    Mol Pharm; 2021 Jul; 18(7):2764-2776. PubMed ID: 34180226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Release Characteristics of an Essential Oil Component Encapsulated with Cyclodextrin Shell Matrices.
    Li Z; Wen W; Chen X; Zhu L; Cheng G; Liao Z; Huang H; Ming L
    Curr Drug Deliv; 2021; 18(4):487-499. PubMed ID: 32735520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterizing and Exploring the Differences in Dissolution and Stability Between Crystalline Solid Dispersion and Amorphous Solid Dispersion.
    Wang X; Zhang L; Ma D; Tang X; Zhang Y; Yin T; Gou J; Wang Y; He H
    AAPS PharmSciTech; 2020 Sep; 21(7):262. PubMed ID: 32975680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preparation, characterization and antitumor of cyclodextrin inclusion of an anti-cancer drug regorafenib].
    Kai-Hang L; Mengying S; Guping T; Xiurong HU
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 46(2):144-152. PubMed ID: 28752706
    [No Abstract]   [Full Text] [Related]  

  • 27. Co-amorphous palbociclib-organic acid systems with increased dissolution rate, enhanced physical stability and equivalent biosafety.
    Zhang M; Xiong X; Suo Z; Hou Q; Gan N; Tang P; Ding X; Li H
    RSC Adv; 2019 Jan; 9(7):3946-3955. PubMed ID: 35518078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation and Characterization of a Ternary Inclusion Complex Containing Hydroxypropyl-β-cyclodextrin and Meglumine for Solubility Enhancement of Poorly Water-Soluble ST-246, an Anti-Smallpox Drug.
    Li X; Yang M; Li Y; Gong W; Wang Y; Shan L; Shao S; Gao C; Zhong W
    Curr Drug Deliv; 2017; 14(8):1130-1143. PubMed ID: 27697036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of gliquidone hypoglycaemic effect in rats by cyclodextrin formulations.
    Miro A; Quaglia F; Sorrentino U; La Rotonda MI; D'Emmanuele Di Villa Bianca R; Sorrentino R
    Eur J Pharm Sci; 2004 Sep; 23(1):57-64. PubMed ID: 15324923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential application of low molecular weight excipients for amorphization and dissolution enhancement of carvedilol.
    Pešić N; Dapčević A; Ivković B; Kachrimanis K; Mitrić M; Ibrić S; Medarević D
    Int J Pharm; 2021 Oct; 608():121033. PubMed ID: 34419592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin.
    Guo B; Zhong S; Li N; Li X; Yi J; Jin M
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1638-43. PubMed ID: 24087855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physico-chemical characterization in solution and in the solid state of clonazepam complexes with native and chemically-modified cyclodextrins.
    Mennini N; Bragagni M; Maestrelli F; Mura P
    J Pharm Biomed Anal; 2014 Feb; 89():142-9. PubMed ID: 24291109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elucidation of the orientation of selected drugs with 2-hydroxylpropyl-β-cyclodextrin using 2D-NMR spectroscopy and molecular modeling.
    Adhikari S; Daftardar S; Fratev F; Rivera M; Sirimulla S; Alexander K; Boddu SHS
    Int J Pharm; 2018 Jul; 545(1-2):357-365. PubMed ID: 29747001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Differential Scanning Calorimetry, Powder X-ray Diffraction, and Solid-state Nuclear Magnetic Resonance Spectroscopy for Measuring Crystallinity in Amorphous Solid Dispersions - Application to Drug-in-polymer Solubility.
    Jarrells TW; Munson EJ
    J Pharm Sci; 2022 Oct; 111(10):2765-2778. PubMed ID: 35421430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computer-Aided Formulation Design for a Highly Soluble Lutein-Cyclodextrin Multiple-Component Delivery System.
    Zhao Q; Miriyala N; Su Y; Chen W; Gao X; Shao L; Yan R; Li H; Yao X; Cao D; Wang Y; Ouyang D
    Mol Pharm; 2018 Apr; 15(4):1664-1673. PubMed ID: 29505718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-amorphous formulation of dipyridamole with p-hydroxybenzoic acid: Underlying molecular mechanisms, physical stability, dissolution behavior and pharmacokinetic study.
    Guo W; Dong X; Li Y; Li C; Tian Y; Gao H; Li T; Zhu H; Wang J; Yang C
    Eur J Pharm Biopharm; 2023 Mar; 184():139-149. PubMed ID: 36709922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement on solubility of fluticasone propionate with cyclodextrins by mechanochemical activation.
    Dai J; Liang X; Su W
    Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):799-806. PubMed ID: 25796157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of high pressure compaction on solubility and intrinsic dissolution of ibuprofen binary mixtures employing standard excipients.
    Ibraheem B; Wagner KG
    Int J Pharm X; 2021 Dec; 3():100075. PubMed ID: 33851132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.